Blair K S, Otero M, Teng C, Geraci M, Ernst M, Blair R J R, Pine D S, Grillon C
Department of Health and Human Services,National Institute of Mental Health, National Institutes of Health,Bethesda, MD,USA.
Psychol Med. 2017 Jul;47(10):1806-1815. doi: 10.1017/S0033291717000265. Epub 2017 Mar 14.
Generalized anxiety disorder (GAD) and social anxiety disorder (SAD) are co-morbid and associated with similar neural disruptions during emotion regulation. In contrast, the lack of optimism examined here may be specific to GAD and could prove an important biomarker for that disorder.
Unmedicated individuals with GAD (n = 18) and age-, intelligence quotient- and gender-matched SAD (n = 18) and healthy (n = 18) comparison individuals were scanned while contemplating likelihoods of high- and low-impact negative (e.g. heart attack; heartburn) or positive (e.g. winning lottery; hug) events occurring to themselves in the future.
As expected, healthy subjects showed significant optimistic bias (OB); they considered themselves significantly less likely to experience future negative but significantly more likely to experience future positive events relative to others (p < 0.001). This was also seen in SAD, albeit at trend level for positive events (p < 0.001 and p < 0.10, respectively). However, GAD patients showed no OB for positive events (t 17 = 0.82, n.s.) and showed significantly reduced neural modulation relative to the two other groups of regions including the medial prefrontal cortex (mPFC) and caudate to these events (p < 0.001 for all). The GAD group further differed from the other groups by showing increased neural responses to low-impact events in regions including the rostral mPFC (p < 0.05 for both).
The neural dysfunction identified here may represent a unique feature associated with reduced optimism and increased worry about everyday events in GAD. Consistent with this possibility, patients with SAD did not show such dysfunction. Future studies should consider if this dysfunction represents a biomarker for GAD.
广泛性焦虑症(GAD)和社交焦虑症(SAD)常合并出现,且在情绪调节过程中与类似的神经功能紊乱有关。相比之下,本文所研究的缺乏乐观情绪可能是广泛性焦虑症所特有的,并且可能成为该疾病的一个重要生物标志物。
对未接受药物治疗的广泛性焦虑症患者(n = 18)、年龄、智商和性别匹配的社交焦虑症患者(n = 18)以及健康对照者(n = 18)进行扫描,同时让他们思考未来自己遭遇高影响或低影响负面事件(如心脏病发作;胃灼热)或正面事件(如中彩票;拥抱)的可能性。
正如预期的那样,健康受试者表现出显著的乐观偏差(OB);与其他人相比,他们认为自己未来经历负面事件的可能性显著更低,但经历正面事件的可能性显著更高(p < 0.001)。社交焦虑症患者也表现出这种情况,尽管对正面事件仅处于趋势水平(分别为p < 0.001和p < 0.10)。然而,广泛性焦虑症患者对正面事件没有表现出乐观偏差(t 17 = 0.82,无统计学意义),并且相对于包括内侧前额叶皮质(mPFC)和尾状核在内的其他两组区域,对这些事件的神经调节显著降低(所有p < 0.001)。广泛性焦虑症组与其他组的进一步差异在于,在包括喙部内侧前额叶皮质在内的区域对低影响事件表现出增强的神经反应(两者均p < 0.05)。
此处确定的神经功能障碍可能代表了广泛性焦虑症中与乐观情绪降低和对日常事件担忧增加相关的独特特征。与这种可能性一致的是,社交焦虑症患者并未表现出这种功能障碍。未来的研究应考虑这种功能障碍是否代表广泛性焦虑症的生物标志物。